🔎 Trials Near Me

Beranda › Sklerosis Multipel › Ohio

Uji klinis Sklerosis Multipel di Ohio

14 studi untuk Sklerosis Multipel mencari peserta di lokasi di Ohio.

Kota di Ohio

Teks studi resmi (Bahasa Inggris)

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • University of Cincinnati Medical Center, Cincinnati
  • Riverside Methodist Hospital, Columbus
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06782490

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

  • Local Institution - Site 104, Columbus
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07840326

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Centerville
  • TG Therapeutics Investigational Trial Site, Centerville
  • TG Therapeutics Investigational Trial Site, Cincinnati
  • dan 4 lainnya
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06433752

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Ohio State University Comprehensive Cancer Center, Columbus
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  • University of Cincinnati, Cincinnati
Menerima pesertaFase 1/2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07477639

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • The Ohio State University- Site Number : 8400009, Columbus
  • The Boster Center for Multiple Sclerosis- Site Number : 8400006, Columbus
Menerima pesertaFase 3
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07325292

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Cleveland Clinic, Cleveland
  • The Ohio State University, Department of Psychiatry, Columbus
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

  • TG Therapeutics Investigational Trial Site, Cleveland
  • TG Therapeutics Investigational Trial Site, Columbus
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06680037

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

  • Research Site, Cleveland
Menerima pesertaFase 1
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07224373

Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis

  • Louis Stokes Cleveland VA Medical Center, Cleveland
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07768761

Understanding and Enhancing Human Health and Movement

  • Louis Stokes Cleveland VA Medical Center, Cleveland
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07738978

Care in Multiple Sclerosis (MS)

  • Cleveland Clinic, Cleveland
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT07011914

Central Vein Sign in Multiple Sclerosis Extension Study

  • Cleveland Clinic Foundation, Cleveland
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 20 Feb 2026 · NCT07424027

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

  • Cleveland State University, Cleveland
Menerima peserta
Usia 22 hingga 75 · Semua jenis kelamin · Diperbarui 24 Sep 2025 · NCT05964829

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.